Literature DB >> 22649195

Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans.

Haibin Huang1, Gary R Ostroff, Chrono K Lee, Sarika Agarwal, Sanjay Ram, Peter A Rice, Charles A Specht, Stuart M Levitz.   

Abstract

Glucan particles (GPs) are Saccharomyces cerevisiae cell walls chemically extracted so they are composed primarily of particulate β-1,3-D-glucans. GPs are recognized by Dectin-1 and are potent complement activators. Mice immunized with Ag-loaded GPs develop robust Ab and CD4(+) T cell responses. In this study, we examined the relative contributions of Dectin-1 and complement to GP phagocytosis and Ag-specific responses to immunization with OVA encapsulated in GPs. The in vitro phagocytosis of GPs by bone marrow-derived dendritic cells was facilitated by heat-labile serum component(s) independently of Dectin-1. This enhanced uptake was not seen with serum from complement component 3 knockout (C3(-/-)) mice and was also inhibited by blocking Abs directed against complement receptor 3. After i.p. injection, percent phagocytosis of GPs by peritoneal macrophages was comparable in wild-type and Dectin-1(-/-) mice and was not inhibited by the soluble β-glucan antagonist laminarin. In contrast, a much lower percentage of peritoneal macrophages from C3(-/-) mice phagocytosed GPs, and this percentage was further reduced in the presence of laminarin. Subcutaneous immunization of wild-type, Dectin-1(-/-), and C3(-/-) mice with GP-OVA resulted in similar Ag-specific IgG(1) and IgG(2c) type Ab and CD4(+) T cell lymphoproliferative responses. Moreover, while CD4(+) Th1 and Th2 responses measured by ELISPOT assay were similar in the three mouse strains, Th17 responses were reduced in C3(-/-) mice. Thus, although Dectin-1 is necessary for optimal phagocytosis of GPs in the absence of complement, complement dominates when both an intact complement system and Dectin-1 are present. In addition, Th-skewing after GP-based immunization was altered in C3(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649195      PMCID: PMC3381926          DOI: 10.4049/jimmunol.1200603

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Immune recognition. A new receptor for beta-glucans.

Authors:  G D Brown; S Gordon
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

2.  A critical role for C5L2 in the pathogenesis of experimental allergic asthma.

Authors:  Xun Zhang; Inken Schmudde; Yves Laumonnier; Manoj K Pandey; Jennifer R Clark; Peter König; Norma P Gerard; Craig Gerard; Marsha Wills-Karp; Jörg Köhl
Journal:  J Immunol       Date:  2010-10-25       Impact factor: 5.422

3.  Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia.

Authors:  Diana C Rosentul; Theo S Plantinga; Marije Oosting; William K Scott; Digna R Velez Edwards; P Brian Smith; Barbara D Alexander; John C Yang; Gregory M Laird; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart-Jan Kullberg; Mihai G Netea; Melissa D Johnson
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

Review 4.  The role of Dectin-1 in the host defence against fungal infections.

Authors:  Rebecca A Drummond; Gordon D Brown
Journal:  Curr Opin Microbiol       Date:  2011-07-29       Impact factor: 7.934

Review 5.  Novel roles of complement in T effector cell regulation.

Authors:  Peter S Heeger; Claudia Kemper
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

6.  Th17 cytokines are critical for respiratory syncytial virus-associated airway hyperreponsiveness through regulation by complement C3a and tachykinins.

Authors:  Monali M Bera; Bao Lu; Thomas R Martin; Shun Cui; Lawrence M Rhein; Craig Gerard; Norma P Gerard
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

7.  Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.

Authors:  Chunjian Qi; Yihua Cai; Lacey Gunn; Chuanlin Ding; Bing Li; Goetz Kloecker; Keqing Qian; John Vasilakos; Shinobu Saijo; Yoichiro Iwakura; John R Yannelli; Jun Yan
Journal:  Blood       Date:  2011-04-29       Impact factor: 22.113

Review 8.  Innate antifungal immunity: the key role of phagocytes.

Authors:  Gordon D Brown
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

9.  Human dendritic cells activated via dectin-1 are efficient at priming Th17, cytotoxic CD8 T and B cell responses.

Authors:  Sudhanshu Agrawal; Sudhir Gupta; Anshu Agrawal
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

10.  Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.

Authors:  Sarika Agarwal; Charles A Specht; Huang Haibin; Gary R Ostroff; Sanjay Ram; Peter A Rice; Stuart M Levitz
Journal:  MBio       Date:  2011-08-30       Impact factor: 7.867

View more
  43 in total

Review 1.  Fungal vaccines and immunotherapeutics.

Authors:  Evelyn Santos; Stuart M Levitz
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Dectin-1 activation controls maturation of β-1,3-glucan-containing phagosomes.

Authors:  Michael K Mansour; Jenny M Tam; Nida S Khan; Michael Seward; Peter J Davids; Sravanthi Puranam; Anna Sokolovska; David B Sykes; Zeina Dagher; Christine Becker; Antoine Tanne; Jennifer L Reedy; Lynda M Stuart; Jatin M Vyas
Journal:  J Biol Chem       Date:  2013-04-22       Impact factor: 5.157

Review 3.  Recent advances in oral vaccine development: yeast-derived β-glucan particles.

Authors:  Rebecca De Smet; Liesbeth Allais; Claude A Cuvelier
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

4.  Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.

Authors:  Maureen M Hester; Chrono K Lee; Ambily Abraham; Payam Khoshkenar; Gary R Ostroff; Stuart M Levitz; Charles A Specht
Journal:  Vaccine       Date:  2019-11-04       Impact factor: 3.641

Review 5.  Exploiting fungal cell wall components in vaccines.

Authors:  Stuart M Levitz; Haibin Huang; Gary R Ostroff; Charles A Specht
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

Review 6.  A review of innate and adaptive immunity to coccidioidomycosis.

Authors:  Chiung-Yu Hung; Amy P Hsu; Steven M Holland; Joshua Fierer
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

7.  Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.

Authors:  George S Deepe; William R Buesing; Gary R Ostroff; Ambily Abraham; Charles A Specht; Haibin Huang; Stuart M Levitz
Journal:  Vaccine       Date:  2018-05-02       Impact factor: 3.641

8.  Progress Toward a Human Vaccine Against Coccidioidomycosis.

Authors:  Garry T Cole; Brady J Hurtgen; Chiung-Yu Hung
Journal:  Curr Fungal Infect Rep       Date:  2012-12-01

9.  Lipoteichoic acid anchor triggers Mincle to drive protective immunity against invasive group A Streptococcus infection.

Authors:  Takashi Imai; Takayuki Matsumura; Sabine Mayer-Lambertz; Christine A Wells; Eri Ishikawa; Suzanne K Butcher; Timothy C Barnett; Mark J Walker; Akihiro Imamura; Hideharu Ishida; Tadayoshi Ikebe; Tomofumi Miyamoto; Manabu Ato; Shouichi Ohga; Bernd Lepenies; Nina M van Sorge; Sho Yamasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

Review 10.  New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches.

Authors:  Joshua J Obar; Tobias M Hohl; Robert A Cramer
Journal:  Cytokine       Date:  2016-05-30       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.